Bahri ELMAS, Onur BİRCAN, Mehmet Fatih ORHAN, Öner ÖZDEMİR

Adölesan Bir Annede Mortal Seyreden H1N1 Pnömoni Vakası

Üst ve alt solunum yollarını tutabilen influenza A (H1N1) virüsü, viral pnömoni başta olmak üzere ağır solunum yolu hastalıkları ve akut solunum yetmezliği sendromuna yol açabilir. İnfluenza A virus enfeksiyonu sağlam çocuklarla birlikte komorbid hastalığı bulunan çocuklar ve gebelik ve lohusalık gibi immünitenin baskılandığı durumlarda da ağır enfeksiyona neden olabilmektedir. On yedi yaşında lohusalık döneminde influenza pnömonisi nedeni ile çocuk yoğun bakım ünitesinde takip edilen hastamız, akut solunum yetmezliği ve pulmoner kanama nedeni ile kaybedilmiştir. Ciddi influenza enfeksiyonlarının kontrol altına alınması ve buna bağlı ölümlerin engellenmesi için risk faktörleri iyi analiz edilip erken dönemde koruyucu önlemler alınmalıdır.

Anahtar Kelimeler:

İnfluenza A (H1N1), Lohusa, Pnömoni

A Mortal H1N1 Pneumonia Case in an Adolescent Mother

The influenza A (H1N1) virus, which may involve the upper and lower respiratory tracts, can lead to severe respiratory diseases, especially viral pneumonia, and acute respiratory failure syndrome. Influenza A virus infection can cause severe infection in healthy children, as well as children with comorbid disease and immunosuppressed conditions such as pregnancy and lactation. A seventeen years old patient who was followed up in pediatric intensive care unit due to influenza pneumonia during postpartum period died due to acute respiratory failure and pulmonary hemorrhage. In order to control severe influenza infections and prevent deaths, risk factors should be analyzed well and preventive measures should be taken in the early period.

Keywords:

Influenza A (H1N1), Lactation, Pneumonia,

PDF

___

1. Mossad SB. The resurgence of swine-origin influenza A (H1N1). Cleve Clin J Med. 2009 Jun;76(6):337-43.
2. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 2009; 361: 680–90.
3. Kinikar AA, Kulkarni RK, Valvi CT, et al. Predictors of mortality in hospitalized children with pandemic H1N1 influenza 2009 in Pune, India. Indian J Pediatr. 2012 Apr;79(4):459-66.
4. Shanks GD. Insights from unusual aspects of the 1918 influenza pandemic. Travel Med Infect Dis. 2015 May-Jun;13(3):217-22.
5. Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019 20 Influenza Season. MMWR Recomm Rep. 2019 Aug 23;68(3):1-21.
6. Centers for Disease Control and Prevention. Influenza antiviral medications: Summary for clinicians. https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm (Accessed on November 21, 2019).
7. Can Ö, Ünal N, Memikoğlu O, ve ark. Pandemik influenza A (H1N1) 2009 virüsü ve klinik tecrübemiz. Yoğun Bakım Dergisi, 2010 9(1), 1-12.
8. Cao B, Li XW, Mao Y, et al; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009 Dec 24;361(26):2507-17.
9. Bhattarai A, Villanueva J, Palekar RS, et al; Pennsylvania Working Group. Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak--Pennsylvania, May-June 2009. Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S102-8.
10. Viboud C, Boëlle PY, Cauchemez S, et al. Risk factors of influenza transmission in households. Br J Gen Pract. 2004 Sep;54(506):684-9.
11. Watanabe T. Renal complications of seasonal and pandemic influenza A virus infections. Eur J Pediatr. 2013 Jan;172(1):15-22.
12. Farias JA, Fernández A, Monteverde E, et al. Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med. 2010 Jun;36(6):1015-22.
13. Fiore AE, Fry A, Shay D, Gubareva L, et al. Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2011;60(1):1–24.
14. Sarkar D, Sarkar S, Anand S et al. Lung protective strategy and prone ventilation resulting in successful outcome in a patient with ARDS due to H1N1. BMJ Case Rep. 2011 Feb 15;2011. pii: bcr1020103420. doi: 10.1136/bcr.10.2010.3420.
15. Nye S, Whitley RJ, Kong M. Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome. Front Pediatr. 2016 Nov 24;4:128. eCollection 2016.
16. Smalley N, MacLaren G, Best D, et al. Outcomes in children with refractory pneumonia supported with extracorporeal membrane oxygenation. Intensive Care Med. 2012 Jun;38(6):1001-7.
17. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA (2009) 302:1888–95.